drugset / Trial / NCT03145766
Immunogenicity and Safety of a Purified Vero Rabies Vaccine
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This multicenter, observer-blind, controlled, randomized, Phase II study was designed to evaluate different formulations of the Purified Vero Rabies Cell vaccine VRVg.
Timeline
- Start
- 2017-04-17
- Primary completion
- 2018-01-08
- Completion
- 2018-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Imovax® Rabies | Vaccine | — | Intramuscular |
| Subject | VRVg 1 | Unknown | — | Intramuscular |
| Subject | VRVg-2 | Vaccine | — | Intramuscular |
| Background | Human Rabies Immunoglobulins (HRIG) | Protein / enzyme biologic | — | Intramuscular |